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The  conversion of  toxin into  toxoid  has  been  studied by  Ehrlich 
(1)  and Ramon  (2-4)  for diphtheria toxin, by Behring and Ransom 
(5),  Lowenstein  (6),  and yon Eisler and Lowenstein  (7)  for tetanus 
toxin, by Weinberg and Goy (8) for the toxins of the B.  bo~ulinus and 
of the gas gangrene anaerobes (i.e., B. oedematiens,  etc.).  Ramon (9) 
has also converted abrin and cobra venom into toxoids.  The change 
was observed to occur spontaneously (Ehrlich (1), Behring and Ransom 
(5)), and also could be induced artificially by means of various physi- 
cal and chemical agents; namely, for tetanus  toxin iodine trichloride 
(Behring and Ransom (5)), formalin (0.1 to 0.2 per cent) and exposure 
to a Nemst lamp (Lowenstein (6)), formalin (0.1  to 0.2 per cent) and 
slight heat (30°C.) (yon Eisler and Lowenstein (7)) ; and for diphtheria 
toxin formalin (0.3 to 0.4 per cent) and heat (40-42°C.)  (Ramon (4)). 
By similar procedures (formalin and heat) abrin, cobra venom (Ramon 
(9),),  and toxins of the B.  botulinus  and the gas gangrene anaerobes 
(Weinberg and Goy (8)) have also been converted into toxoid states. 
These studies elaborated the concept of a toxoid first announced by 
Ehrlich.  In its completed form, the definition of a toxoid is that it is 
a toxin so altered that the toxicity is decreased whereas the  antibody- 
combining capacity and the antigenicity are essentially undiminished. 
It  has  been  observed  (Lowenstein  (6),  Ramon  (4))  that  the  anti- 
genicity of tetanus and diphtheria toxoids varies with the potency of 
the mother filtrates.  It can be estimated by the antitoxin-combining 
capacity, to which it is directly proportional. 
By means of the phenomenon of local skin  reactivity  to bacterial 
filtrates, Shwartzman (10-13) has demonstrated the existence of a new 
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category of bacterial exotoxins.  They are filterable and best obtained 
under  conditions  of  insignificant  cell  autolysis.  The  potency  of  a 
filtrate does not depend solely on the number of bacterial cells iu the 
culture from which it is obtained.  The toxins are highly antigenic. 
The  potency  of  the  factors  necessary  for  the  phenomenon  can  be 
accurately titrated.  They are  neutralizable  in  multiple  proportions 
by specific antisera.  Within  the  same  bacterial  species,  there  may 
be considerable variation in the potency of filtrates obtained from cul- 
tures  of various  strains.  In  a  given  filtrate,  the  potency seems  to 
parallel the lethal effect on rabbits. 
The demonstration of exotoxins of a  new type in a large number of 
unrelated  organisms  as  the  members  of  the  coil-typhoid-dysentery 
group, the meningococcus, the Pneumococcus Type III,  the Strepto- 
coccus  haemolyticus-scarlatinae  (Shwartzman  (12)),  the  gonococcus 
(Shwartzman  (14)),  the Bacillus influenzae  (Haemophilus  influemae) 
(Frisch  (15)),  the  Bacillus  pertussis  (Gross  (16)),  and  the  tubercle 
bacillus (Bieling (17)) was of great importance. 
It was  deemed of interest to determine whether this  type of bac- 
terial toxin could be converted into a  toxoid state.  With this aim in 
view, the following experiments were undertaken. 
Methods and Materials 
These experiments were performed on rabbits which had been employed once 
within the previous week for the elicitafion of the  Shwartzman phenomenon, 
receiving for this purpose a variety of materials.  Only those rabbits were selected 
in which the phenomenon had failed to occur.  Unpublished experiments suggest 
that such rabbits may be more sensitive  to the Shwartzman phenomenon than 
stock rabbits.  Further experiments upon this point are now under way. 
Toxins.--(a) Meningococcus "agar washings" toxic filtrates were prepared and 
titrated as described by Shwartzman (18, 19).  Filtrate 1409 was prepared from 
meningococcus Strain 123, Group I; Filtrate 1675 from meningococcus Strain 383, 
Group II; Filtrate A52 was pooled from Filtrates 1233A, 1233B, 1233C, and 1233D, 
prepared from meningococcus Strains 44B Serum 8, 44B Serum 13, 44B Serum 15, 
and 44B Serum 16, respectively, all Group III (Shwartzman (20)).  Meningococ- 
cus Filtrate 1675 was kept in the refrigerator at 6°C. from June 16,  1931, to Dec. 
18,  1931 (time of retitration).  The tlters of the preparations are indicated in 
Table I. 
(b) 1.  147 cc. of meningococcus "agar washings"  toxic Filtrate 1409 plus 3 cc. 
of 20 per cent formalin to make a total volume of 150 cc. with a final concentration 
of 0.4 per cent formalin were placed in a  ground glass-stoppered  bottle, sealed HERBEI~T  ~.  KLEIN  589 
with paraffiu, and kept in an incubator at 37°C. for 35 days.  The resulting prepa- 
ration is referred to as meningococcus Toxoid 1409A. 
2.  2 cc. of 40 per cent formalin were added to 95 cc. of meningococcus Toxoid 
1409A,  thus making a  final total concentration of 1.2  per cent formalin.  This 
mixture was placed in a  ground glass-stoppered bottle, sealed with paraffin, and 
kept in an incubator at 37°C. for 3 weeks (meningococcus Toxoid 1409B). 
3.  110 cc. of meningococcus "agar washings" toxic Filtrate A52 plus 2.75  cc. 
of 40 per cent formalin (to make a final concentration of 1 per cent formalin) were 
placed in a  ground glass-stoppered bottle, sealed with paraffin, and kept in an 
incubator at 37°C. for 23 days (meningococcus Toxoid A52). 
Sera.--1.  Antimeningococcus Serum H251 was obtained from Horse 8. 
Immunization was started Oct.  13,  1930.  The details of a  similar course of 
immunization have  been  described elsewhere  (Shwartzman  (21)).  In  general, 
this  consisted of  the  following: For 6  weeks,  the  horse  received only weekly, 
subcutaneous injections of B. coli toxin.  Thereafter, an intravenous injection of 
heat-killed B. coli vaccine was made with each subcutaneous injection of B.  coli 
toxin, the dosage of both gradually increasing.  After 6 weeks, polyvalent menin- 
gococcus toxin was added in the material for subcutaneous injection and menin- 
gococcus vaccine in that  for intravenous injection.  Finally the animal received 
intravenously  incubated mixtures of meningococcus toxin and anticoli horse serum. 
Bleeding H251  was performed Mar.  10,  1931. 
2.  Serum H230 was obtained from Horse 60 which was immunized in order to 
obtain the auxiliary antibody (Shwartzman (21)). 
Immunization was begun June 27,  1930.  The animal received weekly subcu- 
taneous  injections of polyvalent B.  coli  toxin,  of gradually increasing dosage. 
Intravenous injections were started Sept. 12, 1930.  They consisted of increasing 
amounts of polyvalent heat-killed B. coli vaccine.  In the last 5 weeks of immuni- 
zation, 3 intravenous injections were made of incubated mixtures of polyvalent B. 
coli toxin and anticoli horse serum.  The course of immunization lasted 8 months 
with one period of rest for 3 weeks.  Bleeding H230 was performed Feb. 11, 1931. 
3.  Serum  H290  was  a  later bleeding from  Horse  60.  After 2  weeks'  rest, 
immunization was continued.  The animal received 4 subcutaneous injections of 
polyvalent B. coli toxin, 2 intravenous injections of B. coli vaccine, and 2 intra- 
venous injections of incubated mixtures of B. coli toxin and Serum H230.  Bleed- 
ing H290 was performed Apr. 28, 1931. 
1Feu2ralizafions.--Neutralizations  of the toxins and toxoids by the horse sera 
were carried out as described by Shwartzman (19). 
Agglutina$ions.--Agglutinations  were carried out with  standard suspensions of 
live 24 hour cultures of meningococci.  Mixtures of 0.25 cc. of bacteria and 0.25 cc. 
of serum were kept in a water bath at 37°C. for 18 hours and then read promptly. 
Precipitations.--Mixtures  were made of 0.2  cc.  serum  and  0.2 cc.  toxoid, 0.2 
cc.  serum and 0.05  cc.  toxoid, 0.05  cc.  serum and 0.05  cc.  toxoid, and  0.05  cc. 
serum and 0.2 cc. toxoid.  The mixtures were similarly incubated.  Precipitations 
were also carried out using toxin as precipitinogen. 590  SHWARTZMAN  PHENOMENON.  I 
Titration of Meningococcus Skin-Preparatory and Reacting Factors 
It has been demonstrated by Shwartzman (13)  that there exists a 
quantitative reciprocal relationship between the skin-preparatory and 
reacting factors of unrelated potent toxins.  Therefore, with the use of 
meningococcus Toxin 1409 skin-preparatory factors it was possible to 
test meningococcus Toxoids 1409A and B for reacting factors and with 
meningococcus Toxin  1409 reacting  factors  to  test  meningococcus 
Toxoids 1409A and B  for skin-preparatory factors.  The results are 
summarized in Table I. 
As is seen from Table I  (Groups 1 and 2), meningococcus Toxin 1409 
had  a  titer  of  1400  reacting units.  Meningococcus Toxoid  1409A 
used for preliminary experiments was not titrated to the end-point. 
However, it is seen from Table I  (Groups 3 and 4), that there was a 
considerable  reduction  in  skin-preparatory  and  reacting  potency. 
Thus, of 3 rabbits which received 0.25 cc. of undiluted meningococcus 
Toxoid 1409A intradermally, and 24 hours later an intravenous injec- 
tion of 64  reacting units of meningococcus Toxin  1409  per kilo of 
body weight, 1 rabbit developed a strong and 1 a weak reaction.  Of 3 
rabbits  which  received 0.25  cc.  of undiluted meningococcus Toxin 
1409 intradermally and 24 hours later an intravenous injection of 1 cc. 
of meningococcns Toxoid 1409A diluted 1 : 22 (a dilution corresponding 
to 64 reacting units of meningococcus  Toxin 1409--the mother filtrate) 
per kilo of body weight, only 1 developed a positive reaction and that 
of moderate intensity.  Mter an intravenous injection of 64 reacting 
units  of  meningococcus Toxin  1409 at  least  2  of  3  rabbits  show 
strongly positive reactions. 
Meningococcus Toxoid 1409B had no skin-preparatory factors for 
64 and  128 reacting units of meningococcus Toxin 1409 per kilo of 
body weight (Table I, Groups 5 and 6).  Using meningococcus Toxin 
1409 skin-preparatory factors, meningococcus Toxoid 1409B revealed 
only about 17 reacting units per cc. (Table I, Groups 7 and 8).  Menin- 
gococcus Toxoid 1409B, therefore possessed no skin-preparatory fac- 
tors and only 1.2 per cent of the reacting factors present in the mother 
filtrate. 
Incidentally, it is of interest to note that following the intradermal 
injection of a toxoid preparation, there developed at the injected skin 
site an area of blanching 10 to  15 ram. in diameter surrounded by a 1"4 
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purpuric zone 1 to 2 mm.  in width.  A  similar observation has been 
made by Bumet (22) who suggested that spontaneous local desensitiza- 
tion might be taking place in the center of the skin sites injected with 
toxoid preparations.  However, control injections of 0.25 cc. of  1 per 
cent  formalin  produce  the  same  effect.  Pituitrin  (Klein  (23))  and 
adrenalin  have a  similar  action on the rabbit's  skin.  This  circinate 
distribution  of the purpuric  reaction at  the prepared  skin  site must 
therefore  be  considered  as  a  non-specific  manifestation  of  primary 
local toxicity of the injected substances. 
A Besredka (24) disintegrate of a B. dysenteriae Flexner strain to which 0.2 per 
cent formalin had been added and which had been kept at 37°C. for 1 month was 
referred to by Burner as toxoid.  His toxoid preparation  suffered a loss only in 
skin-preparatory, but not in reacting potency (no titrations  to the end-point), as 
compared with the mother filtrate.  Studies of the antibody-combinlng capacity 
or antigenlcity are not mentioned. 
Titration  of Antibody-Combining  Capacity  of Menlngococcus  Toxolds 
Neutralized  mixtures  of meningococcus Toxin  1409 and  meningo- 
coccus Toxoid 1409B with antimeningococcus horse Serum H251 and 
auxiliary antibody Serum H230 were titrated as described by Shwartz- 
man  (21).  The results  are  summarized in Table II (Groups 1 to 5). 
As is seen from Group 1 of Table II,  consistent  neutralization  was 
obtained with 100 units of meningococcus Toxin 1409  (1 cc. of a  1 : 14 
dilution  of meningococcus  Toxin  1409).  With  the  use  of an  equal 
amount of serum, consistent neutralization was obtained with only 1.7 
units  of meningococcus  Toxoid  1409B  (1  cc.  of  a  1:10  dilution  of 
meningococcus Toxoid 1409B) (Table II, Group 3).  The ratio of the 
antibody-combining capacity of meningococcus Toxoid 1409B to that 
of meningococcus Toxin 1409 is, therefore, that of 10:14, thus showing 
in the toxoid a  loss of only 28.7 per cent of the antibody-combining 
capacity  associated  with  a  98.8  per  cent  loss  of  toxicity  as  com- 
pared to the mother filtrate. 
It  remained  to  determine  whether  1.7  reacting  units  of meningo- 
coccus Toxoid 1409B actually held in combination all of the neutraliz- 
ing antibody in the serum used for the neutralization titrations (0.9 cc. 
of  Serum  H251  plus 0.1  cc.  of Serum  H230).  If the  mixture  con- 
tained an excess, i.e. unbound antibody, then consistent neutralization HERBERT M.  KLEIN  593 
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should still be obtained after the addition of a  small amount of toxin 
to the mixture.  Accordingly the following experiment was performed. 
Each of 4 rabbits received an intradermal injection  of 0.25 cc. of undiluted 
meningococcus Toxin 1409 followed 24 hours later by an intravenous injection of 
a mixture of 1 cc. of meningococcus Toxoid 1409B diluted 1 : 10 (1.7 reacting units) 
plus 0.9 cc. of Serum H251 plus 0.1 cc. of Serum H230 plus 0.5 cc. of meningococcus 
Toxin 1409 diluted 1 : 70 (10 reacting units) per kilo of body weight.  Reactions 
were elicited in 3 of the 4 rabbits (no neutralization). 
This demonstrates conclusively that 1.7 reacting units of meningo- 
coccus Toxoid  1409B  actually combined with all of the neutralizing 
antibody in 0.9 cc. of Serum H251  plus 0.1 cc. of Serum H230. 
Spontaneous Meningococcus Toxoid Formation 
The titer of reacting units of a  bacterial filtrate potent in eliciting 
the  phenomenon  often  diminishes  on  standing  (Shwartzman  (13)). 
It was observed  by Ehrlich  (1)  that,  on  standing,  diphtheria  toxin 
often  suffered  a  decrease  in  the  titer  of  direct  toxicity whilst  the 
antitoxin-combining power  remained  essentially unaltered.  It  was, 
therefore, of interest to determine whether the decrease in the titer of 
reacting units of a  bacterial filtrate which occurred on standing was 
associated with a diminution of the antibody-combining capacity. 
For this purpose the following was done. 
The preparation of meningococcus "agar washings"  toxic  Filtrate 1675 was 
completed on June 16, 1931.  In the period, July 15 to 17, 1931, the titer of react- 
hag units and the antibody-combining capacity were determined.  These determi- 
nations were performed on stock rabbits.  Antimeningococcus horse Serum H251 
and anticoli horse Serum H290 were used for the neutralization experiments.  In 
the period Dec. 18 to 23, 1931, these determinations were repeated on used rabbits. 
The results are summarized in Table I (Groups 13 to 16) and Table II (Groups 6 
to 9). 
As is seen from Table I, despite the possibly increased sensitivity 
of used rabbits,  the titer of reacting units dropped from 1300 to  150 
units.  However, the same amount of serum  (0.9 cc. of Serum H251 
plus 0.1  cc. of Serum H290)  which consistently neutralized 1 cc. of a 
1:10 dilution of meningococcus Toxin 1675  in July was necessary for 
consistent neutralization of 1 cc. of a  1 : 13.6 dilution of meningococcus 
Toxin  1675  in  December  (Table  II,  Groups  6  to 9).  Therefore,  in HERBERT  M,  KLEIN  595 
December, the toxin retained but 11.5 per cent of the July reacting 
titer.  In contrast with this, in December, it retained 73.5 per cent of 
the  antibody-combining  capacity  present  in  July.  The  relative 
preservation of the antibody-combining capacity, despite the decrease 
in  titer of reacting units which takes place in meningococcus toxin 
on standing, resembles closely, therefore, the transformation of diph- 
theria toxin into toxoid under similar conditions. 
Lethal Effect of Meningococcus Toxoid 
An intravenous injection of an "agar washings" toxic filtrate pro- 
duces a  considerable mortality in  rabbits.  There appears  to  be  a 
definite parallelism between the lethal effect and the titer of reacting 
TABLE  m 
Lethal Effect of Filtrates Studied 
Group 
No.  Intravenous injection per kwt. 
1 CC. mngo T  A52 diluted 1: 5 
1 "  "  Toxoid A52 undiluted 
2  "  "  "  A52  " 
No. of 
rescdug 
units 
150 
23 
46 
No. of 
rabbits 
3 
3 
3 
Reset 
1  died  after  2  hrs. 
2  survived 
All survived 
units of a given filtrate (Shwartzman (13)).  It was of interest, there- 
fore, to determine whether the decrease brought about in the titer of 
reacting units in meningococcus toxoid preparations, was associated 
with a parallel decrease in lethal effect. 
From Table I  (Groups 9 and 10), it can be seen that meningococcus 
Toxin A52 possessed a titer of 750 reacting units.  In contrast to this 
meniugococcus Toxoid A52 possessed a titer of only about 23 reacting 
units (Table I, Groups 11 and 12).  The lethal effect of both of these 
filtrates was studied.  The results are summarized in Table III. 
Of 3  rabbits which received intravenously 1 cc. of meningococcus 
Toxin A52  diluted 1:5  (150 units) per kilo of body weight, 1 died 2 
hours after the injection, and the others survived (Table III, Group 1). 
Two groups, each of 3 rabbits, received intravenous injections of 1 cc. 
and 2  cc., respectively, of undiluted meningococcus Toxoid A52 per 
kilo of body weight; all survived (Table III, Groups 2 and 3). 596  SHWARIZMAN  PHENOMENON.  I 
It can be stated that death following an intravenous injection of a 
meningococcus  filtrate  generally  occurs  within  4  hours.  In  these 
experiments, the surviving rabbits were observed for 3 days after the 
injection and showed no signs of intoxication. 
Occasionally a  death occurs after an intravenous injection of 10 to 
25 units per kilo of body weight.  An injection of from 50 to 100 units 
is frequently followed by death.  It appears that an injection of from 
100 to 200 units is regularly associated with mortality, the percentage 
being proportional to the dosage.  From Table III  (Group 1), it can 
be seen that  an  injection  of  150 units  of meningococcus Toxin  A52 
was followed by the death of 1 of 3 rabbits.  From Groups 2 and 3, it 
can be seen that the injection of 1 and 2 cc. of meningococcus Toxoid 
A52  representing  the  volume of  750  and  1500  units  of  the  mother 
filtrate (meningococcus Toxin A52) per kilo of body weight, was toler- 
ated perfectly well by the 6  animals  injected.  This  demonstrates  a 
striking  diminution  in the lethal  effect of the toxoid as compared to 
the mother filtrate. 
Antigenicity of Meningococcus Toxoid 
It remained to ascertain the antigenicity of a meningococcus toxoid 
preparation; e.g., meningococcus TOxoid  1409B.  Lowenstein  (6) had 
noted  that  the antigenicity of a  tetanus  toxoid was directly propor- 
tional to its antitoxin-combining  capacity.  In view of the fact that 
meningococcus Toxoid 1409B possessed 71.3 per cent of the antibody- 
combining capacity of the mother filtrate (meningococcus Toxin 1409), 
it was expected that the toxoid would still be antigenic. 
6 rabbits were immunized, each by intradermal injections of 0.5 cc. of undiluted 
meningococcus Toxoid 1409B on Jan.  30, Feb. 5, 10, 17, and 24, and by intra- 
venous injection on Feb. 6, 11, 18, and 25 of 1 cc. of meningococcus Toxoid 1409B 
diluted  1 :  20, 1  : 10, 1 :  5, and undiluted, respectively, per kilo of body weight.  3 
of the rabbits survived until Feb. 29, when they were bled.  A standard suspension 
of a  24 hour  culture  of menlngococcus Strain  123, Group  1 (the  strain  which 
furnished meningococcus Toxin 1409), was agglutinated  with  the sera of these 
animals.  The results are set down in Table IV.  For comparison, the same sus- 
pension of menlngococci was agglutinated  with Serum R332, a stock, Group 1, 
meningococcus, rabbit agglutinating serum. 
As can be seen from Table IV, the agglutinating  titers of the sera 
produced by immunization  with meningococcus Toxoid 1409B varied HERBERT  M.  KLEII~  597 
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from 320 to 1280,  whereas the control serum had a  titer of only 160. 
Sera obtained from trial bleedings of the rabbits performed January 28, 
1932,  were free of spontaneous agglutinins  for  meningococci.  The 
sera contained no precipifins either for meningococcus Toxin 1409 or 
meningococcus Toxoid  1409B.  The  sera  were unable  to  neutralize 
meningococcus Toxin 1409 reacting factors (1 cc. of serum mixed with 
3  units of toxin).  However, rabbits  do not readily form precipitins 
for bacterial filtrates nor are they good antitoxin producers.  Never- 
theless, further studies are under way with the aim of producing pre- 
cipitating and antitoxic rabbit sera. 
DISCUSSION 
The  experiments  cited  demonstrate  that  rneningococcus  culture 
filtrates treated with formalin and heat can be modified similarly  to 
diphtheria toxin.  The toxicity, as measured by the titer of reacting 
units, and the lethal effect are markedly decreased.  In contrast, the 
antigenlcity  and  the  antibody-combining  capacity  are  essentially 
unimpaired. 
Furthermore, no comparable loss in antibody-combining capacity is 
associated  with  the  decrease  in  toxicity  occurring  on  standing. 
Ramon  (4)  by precipitation  tests  has  found that  diphtheria  toxoid 
flocculates with diphtheria antitoxin to the same titer as the mother 
filtrate  (toxin). 
It was the detoxifying alteration of the sort undergone by diphtheria 
toxin that led Ehrlich to the description of diphtheria toxoid.  Since 
meningococcus culture  filtrates  can  spontaneously  or  artificially  be 
modified in a  similar manner, it appears justifiable to consider such a 
modified meningococcus culture filtrate as rneningococcus toxoid. 
As indicated in the introductory section, all of the classical toxins 
can be converted into toxoid states.  The production of a  meningo- 
coccus toxoid is further evidence of the similarity in properties between 
the  bacterial  exotoxins  studied  by  Shwartzman  and  the  classical 
bacterial exotoxlns, e.g., diphtheria and tetanus. 
The demonstration of a  meningococcus toxoid has  a  considerable 
practical importance.  It is common experience that animals used for 
the production of therapeutic sera  eventually succumb to the  toxic 
effects of the injected antigens.  Since toxoids show lithe lethal effect, IIERBERT  ~. KLEIN  599 
it  is  suggested that  they be  employed in  the production of thera- 
peutic sera. 
As yet unpublished experiments suggest that  serum from certain 
human beings may possess the capacity to neutralize meningococcus 
reacting units.  Since meningococcus toxoid is  antigenic and has  a 
very low titer in reacting units (relatively non-toxic), it may possibly 
be of use in the active immunization of man against meningococcus 
infections. 
It is still common practice to evaluate therapeutic meningococcus 
sera by their agglutinin titers.  However, this criterion of evaluation 
reveals a lack of correlation between the agglutinin titer and the thera- 
peutic efficacy of a  serum.  Recently, Shwartzman (20, 25) has sug- 
gested that therapeutic meningococcus sera be graded by their capac- 
ity  to  neutralize  meningococcus  reacting  factors.  However,  the 
demonstration of toxoid formation should be taken into consideration 
inasmuch as, in filtrates with different degrees of toxoid formation, the 
same number of reacting units may represent varying antibody-com- 
bining capacities. 
It would seem advisable to keep as a  standard an immune serum 
which had been titrated against freshly prepared meningococcus toxin, 
in  which only insignificant, if any,  toxoid formation had occurred. 
Other sera could then be compared to this by their capacity to neu- 
tralize any given meningococcus filtrate. 
SUMMARY  AND  CONCLUSIONS 
Formalin induces a  considerable change in meningococcus culture 
filtrates.  This consists of a marked decrease in toxicity as concerns 
both the Shwartzman phenomenon and the lethal effect, with relative 
preservation of the antibody-combining capacity and antigenicity. 
A similar modification occurs spontaneously in meningococcus cul- 
ture filtrates on standing. 
Inasmuch as these changes parallel those occurring in the conver- 
sion of diphtheria toxin into toxoid, it is justifiable to consider such 
altered meningococcus toxin as meningococcus toxoid. 
I am indebted to Dr. Gregory Shwartzman for many kindnesses and 
invaluable assistance. 600  SHWARTZMAN PHENOMENON.  I 
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